ZYME stock forecast
Our latest prediction for Zymeworks BC Inc's stock price was made on the June 22, 2023 when the stock price was at 8.34$.
In the short term (2weeks), ZYME's stock price should underperform the market by -3.12%. During that period the price should oscillate between -8.56% and +3.45%.
In the medium term (3months), ZYME's stock price should underperform the market by -8.75%. During that period the price should oscillate between -29.68% and +8.49%.
Get email alertsCreate a solid portfolio with ZYME
About Zymeworks BC Inc
zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.08$ per share.
The book value per share is 5.83$
Three months stock forecastJune 22, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -77M | - | -72M | -1.08 | - | - | 64M | 5.83 | - | - | - |